Literature DB >> 28876295

Y Chromosome DNA in Women's Vaginal Samples as a Biomarker of Recent Vaginal Sex and Condom Use With Male Partners in the HPV Infection and Transmission Among Couples Through Heterosexual Activity Cohort Study.

Talía Malagón, Ann Burchell, Mariam El-Zein, Julie Guénoun, Pierre-Paul Tellier, François Coutlée, Eduardo L Franco.   

Abstract

BACKGROUND: Y chromosome DNA from male epithelial and sperm cells was detected in vaginal samples after unprotected sex in experimental studies. We assessed the strength of this association in an observational setting to examine the utility of Y chromosome DNA as a biomarker of recent sexual behaviors in epidemiological studies.
METHODS: The HPV (human papillomavirus) Infection and Transmission Among Couples Through Heterosexual Activity cohort study enrolled 502 women attending a university or college in Montréal, Canada, and their male partners from 2005 to 2010. Participants completed self-administered questionnaires. We used real-time polymerase chain reaction to test women's baseline vaginal samples for Y chromosome DNA and assessed which sexual behaviors were independent predictors of Y chromosome DNA positivity and quantity with logistic and negative binomial regression.
RESULTS: Y chromosome DNA positivity decreased from 77% in women in partnerships reporting vaginal sex 0 to 1 day ago to 13% in women in partnerships reporting last vaginal sex of 15 or more days ago (adjusted odds ratio, 0.09; 95% confidence interval, 0.02-0.36). The mean proportion of exfoliated vaginal sample cells with Y chromosome DNA was much lower for women who reported always using condoms (0.01%) than for women who reported never using condoms (2.07%) (adjusted ratio, 26.8; 95% confidence interval, 8.9-80.5). No association was found with reported oral/digital sex frequency or concurrency of partnerships.
CONCLUSIONS: Y chromosome DNA quantity is strongly associated with days since last vaginal sex and lack of condom use in observational settings. Y chromosome DNA quantity may prove useful as a correlate of recent vaginal sex in observational studies lacking data on sexual behavior, such as surveillance studies of human papillomavirus infection prevalence.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28876295      PMCID: PMC5726892          DOI: 10.1097/OLQ.0000000000000688

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  31 in total

1.  Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA.

Authors:  Roxanne Jamshidi; Ana Penman-Aguilar; Jeffrey Wiener; Maria F Gallo; Jonathan M Zenilman; J H Melendez; Margaret Snead; Carolyn M Black; Denise J Jamieson; Maurizio Macaluso
Journal:  Contraception       Date:  2013-08-14       Impact factor: 3.375

2.  Polymerase chain reaction detection of Y-chromosome sequences in vaginal fluid of women accessing a sexually transmitted disease clinic.

Authors:  Rosemary A Jadack; Jeffrey Yuenger; Khalil G Ghanem; Jonathan Zenilman
Journal:  Sex Transm Dis       Date:  2006-01       Impact factor: 2.830

3.  The best approach for early prediction of fetal gender by using free fetal DNA from maternal plasma.

Authors:  Elena Picchiassi; Giuliana Coata; Alessia Fanetti; Michela Centra; Luana Pennacchi; Gian Carlo Di Renzo
Journal:  Prenat Diagn       Date:  2008-06       Impact factor: 3.050

4.  The use of biomarkers of semen exposure in sexual and reproductive health studies.

Authors:  Margaret Christine Snead; Carolyn M Black; Athena P Kourtis
Journal:  J Womens Health (Larchmt)       Date:  2014-09-30       Impact factor: 2.681

5.  Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure.

Authors:  M Macaluso; L Lawson; R Akers; T Valappil; K Hammond; R Blackwell; G Hortin
Journal:  Contraception       Date:  1999-03       Impact factor: 3.375

6.  Condom use and vaginal Y-chromosome detection: the specificity of a potential biomarker.

Authors:  Khalil G Ghanem; Johan H Melendez; Corlina McNeil-Solis; Julie A Giles; Jeffrey Yuenger; Tukisa D Smith; Jonathan Zenilman
Journal:  Sex Transm Dis       Date:  2007-08       Impact factor: 2.830

7.  Human papillomavirus infections among couples in new sexual relationships.

Authors:  Ann N Burchell; Pierre-Paul Tellier; James Hanley; François Coutlée; Eduardo L Franco
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

Review 8.  Biological markers of sexual activity: tools for improving measurement in HIV/sexually transmitted infection prevention research.

Authors:  Maria F Gallo; Markus J Steiner; Marcia M Hobbs; Lee Warner; Denise J Jamieson; Maurizio Macaluso
Journal:  Sex Transm Dis       Date:  2013-06       Impact factor: 2.830

9.  Telling truth from Ys: an evaluation of whether the accuracy of self-reported semen exposure assessed by a semen Y-chromosome biomarker predicts pregnancy in a longitudinal cohort study of pregnancy.

Authors:  Janet E Rosenbaum; Jonathan Zenilman; Johan Melendez; Eve Rose; Gina Wingood; Ralph DiClemente
Journal:  Sex Transm Infect       Date:  2014-03-13       Impact factor: 3.519

10.  Mechanism of human papillomavirus binding to human spermatozoa and fertilizing ability of infected spermatozoa.

Authors:  Carlo Foresta; Cristina Patassini; Alessandro Bertoldo; Massimo Menegazzo; Felice Francavilla; Luisa Barzon; Alberto Ferlin
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

View more
  2 in total

Review 1.  The Value of Assessing Self-Reported and Biological Indicators of Outcomes in Evaluating HIV Programs.

Authors:  Rick S Zimmerman; Purnima Mehrotra; Tessa Madden; Rachel Paul
Journal:  Curr HIV/AIDS Rep       Date:  2021-05-16       Impact factor: 5.071

2.  PrEP Use Among Female Sex Workers: No Evidence for Risk Compensation.

Authors:  Katia Giguère; Luc Béhanzin; Fernand A Guédou; Denis Talbot; François A Leblond; Ella Goma-Matsétsé; Djimon M Zannou; Dissou Affolabi; René K Kêkê; Flore Gangbo; Moussa Bachabi; Michel Alary
Journal:  J Acquir Immune Defic Syndr       Date:  2019-11-01       Impact factor: 3.731

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.